Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/ddg.13064_g | DOI Listing |
Clin Transl Allergy
February 2022
Novartis Pharma AG, Basel, Switzerland.
Background: Chronic spontaneous urticaria (CSU) negatively impacts patients' sleep, thereby reducing health-related quality of life (HRQoL). Half of patients with inadequately controlled CSU report sleep interference often or every night, which can lead to depression, anxiety, social, and work-related problems.
Methods: This randomized, double-blind, placebo-controlled Phase 2b core study (NCT02477332) included adult patients ≥18 years with moderate to severe CSU inadequately controlled with H -antihistamines.
Clin Transl Allergy
December 2021
Institute for Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
J Dtsch Dermatol Ges
November 2016
Department of Dermatology and Venereology, Sechenov First Moscow State Medical University, Moskau, Russland.
Hautarzt
September 2013
Klinik für Dermatologie, Venerologie und Allergologie, Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland.
The identification of the causes of chronic spontaneous urticaria (CSU) is difficult. The recognition of functional autoantibodies against FcεRI and/or against IgE in some patients with CSU led to the concept of autoimmune etiology of the disease. Clinical and laboratory features in a subpopulation of CSU patients also point to an autoimmune etiology of the disease.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!